A resource of Calculate by QxMD at https://www.qxmd.com/calculate
Over 400 decision support tools available • get the app for iOS or Android at qx.md/calculate
Once a diagnosis of AKI has been made, the next step is to stage it (Recommendation 2.1.2). Like diagnosis, staging requires reference to a baseline SCr when SCr criteria are used. This baseline becomes the reference SCr for staging purposes. Table 10 shows the maximum stage for each Case described in Table 7. Staging for Case A was already mentioned. The maximum stage is 2 because reference SCr is 1.0 mg/dl (88 µmol/l) and the maximum SCr is 2.0 mg/dl (177 µmol/l). Had the reference SCr been 0.6 mg/dl (53 µmol/ l), the maximum stage would have been 3. Case F was staged by using the lowest SCr (1.0 mg/dl [88 µmol/l]) as the reference. Of course, the actual baseline for this case might have been lower but this would not affect the stage, since it is already Stage 3. Note that if this patient was a 35-year-old white male, his MDRD estimated baseline SCr would be 1.2 mg/dl (106 µmol/l) (Table 9) and his initial stage on admission (day 1) would be assumed to be 2. However, once his SCr recovered to 1.0 mg/dl (88 µmol/l) on day 7, it would be possible to restage him as having had Stage 3. Once he has recovered, there may be no difference between Stage 2 or 3 in terms of his care plan. On the other hand, accurately staging the severity of AKI may be important for intensity of followup and future risk.
Note that Cases G and H can only be staged if the reference SCr can be inferred. Case G may be as mild as stage 1 if the baseline is equal to the nadir SCr on day 7. On the other hand, if this case were a 70-year-old white female with no known evidence or history of CKD, the reference SCr would be 0.8 mg/dl (71 µmol/l) based on an estimated baseline (Table 9). In this case, the severity on day 1 would already be stage 2.
Do you have an enquiry or suggestion? Get in touch with us through Twitter @QxMD, Facebook QxMD, or email contact@qxmd.com